Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Harding Loevner International Small Companies Equity 2025 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Harding Loevner International Small Companies Equity)

Primary Source Intelligence • Q1 2025 Letter Analysis

Harding Loevner International Small Companies Equity Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Harding Loevner International Small Companies Equity. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD-10.48%

YTD-6.16%

Annualized+6.09%

Positioning StanceConstructive

Market CapSmallCap

GeographyGlobal

Digest Analysis

Quick Take

"International small-cap fund underperformed in 2024 due to currency headwinds and sector-specific weakness, but maintains focus on quality-growth companies with superior fundamentals."

Executive Summary

Harding Loevner's International Small Companies Equity composite declined 10.3% in Q4 2024 and 5.3% for the full year, underperforming the MSCI ACWI ex US Small Cap Index which fell 7.6% in the quarter but gained 3.9% for the year. Currency weakness accounted for 85% of the quarterly decline in international small caps. The portfolio's underperformance was primarily driven by weak stocks in Health Care, Industrials, and Information Technology sectors, with major detractors including CellaVision, LEM Holdings, and several emerging market holdings. Despite challenging market conditions for quality-growth small companies, the manager maintains conviction in their investment approach, noting that portfolio companies continue to exhibit superior fundamentals including higher profit margins, returns on equity, and healthier balance sheets compared to the benchmark. The valuation premium for quality-growth companies has substantially narrowed, creating better future return opportunities. The manager recently added Carl Zeiss Meditec and Shift at attractive valuations, emphasizing their focus on competitively advantaged businesses with strong growth prospects.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

72%

CautiousHigh

High Conviction (72%)

High conviction evidenced by maintaining concentrated portfolio of ~80 holdings with detailed fundamental analysis of individual companies. Manager provides specific reasoning for holding underperforming stocks and adds new positions despite recent weakness. Clear investment philosophy consistently applied.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager acknowledges challenging market conditions and currency headwinds but expresses optimism about future opportunities created by narrowed valuations. They see the current environment as creating better return prospects for quality companies.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

The portfolio maintains full investment in quality-growth small caps with recent additions of new positions. Cash level is low at 2.4%, indicating continued risk appetite despite challenging conditions.

Capital Deployment

20%

De-riskingDeploying

De-risking (20%)

Moderate deployment activity with addition of two new positions (Carl Zeiss Meditec and Shift) while maintaining low 2.4% cash level. Some portfolio turnover with sales of underperformers like Localiza, but overall net neutral deployment.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The manager is selectively adding new positions like Carl Zeiss and Shift, taking advantage of improved valuations. They express intention to continue emphasizing highest-quality companies while being opportunistic about entry points.

Language Signal

15%

BearishBullish

Bearish (15%)

Language is balanced with acknowledgment of challenges but emphasis on opportunities. Terms like 'attractive valuations,' 'better future return opportunities,' and 'strong businesses' are offset by discussion of headwinds and underperformance.

Perceived Risk

65%

Low RiskElevated

Elevated Risk (65%)

Manager identifies multiple specific risks including currency headwinds, macroeconomic uncertainty, geopolitical tensions, and the challenging environment for small caps. Discusses prolonged underperformance and structural headwinds facing the asset class.

Opportunity Density

70%

ScarceAbundant

Abundant (70%)

Manager sees improving opportunity set due to narrowed valuation premiums for quality companies. Recent additions of Carl Zeiss and Shift demonstrate ability to find attractive investments, though selectivity remains important in the current environment.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Long-term investment approach evidenced by holding underperforming stocks based on fundamental conviction and multi-year growth projections. Manager discusses five-year revenue and earnings growth expectations, indicating patient capital approach with multi-year investment horizons.